WHO experts issue recommendations on Moderna COVID-19 vaccine

By: |
Updated: January 26, 2021 5:52 PM

The WHO's Strategic Advisory Group of Experts on Immunization, known as SAGE, advised in a series of recommendations issued after reviewing data that the vaccine not be used on pregnant women unless they are health workers or have conditions putting them at high risk.

A World Health Organization (WHO) panel of experts recommended on Tuesday that the Moderna COVID-19 vaccine be given in two doses at an interval of 28 days, which could be extended under exceptional circumstances to 42 days.A World Health Organization (WHO) panel of experts recommended on Tuesday that the Moderna COVID-19 vaccine be given in two doses at an interval of 28 days, which could be extended under exceptional circumstances to 42 days.

A World Health Organization (WHO) panel of experts recommended on Tuesday that the Moderna COVID-19 vaccine be given in two doses at an interval of 28 days, which could be extended under exceptional circumstances to 42 days.The WHO’s Strategic Advisory Group of Experts on Immunization, known as SAGE, issued a series of recommendations on Moderna, several weeks after issuing their guidance on the rival Pfizer shot.

After reviewing Moderna data the independent experts said that that vaccine not be used on pregnant women unless they are health workers exposed to the virus or have medical conditions putting them at high risk.”The main recommendation for the use of this vaccine is that based on the current elements we recommend it should be given in doses of 100 micrograms or 0.5 ml with an interval of 28 days,” Alejandro Cravioto, panel chair, told a news briefing in Geneva.

“This interval might be moved to 42 days but the evidence we have does not go behond that time,” he said, speaking from Mexico.WHO director of immunisation Kate O’Brien said that clinical trials of the Moderna vaccine were needed on pregnant women.”There is no reason to think there could be a problem in pregnancy, we are just acknowledging the data is not there at the moment,” she said.The WHO was liaising with Moderna on data it submitted as part of its application for WHO emergency use listing and would make a decision soon, she added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1UK’s PM Boris Johnson: G7 pledge 1 billion vaccine doses to poorer nations
2AstraZeneca shots should be halted for over-60s – EMA official
3G7 leaders discuss Wuhan lab leak theory behind COVID-19 pandemic